COVID-19: oxidative stress and the relevance of antioxidant therapy
Open Access
- 21 September 2020
- journal article
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
Abstract
The emergence of viral respiratory pathogens with high pandemic potential, such as the SARS-CoV-2, poses a serious public health problem, with a very limited arsenal of effective tools and techniques to prevent and treat a new pandemic infection. The literature on the involvement of reactive oxygen species in the pathogenesis of coronavirus infections and the potential for antioxidant therapy was reviewed. Because of available evidence on the involvement of oxidative stress in the mechanisms of initiation and maintenance of homeostasis disorders in SARS-CoV-2, approaches combining reduction of ROS synthesis, inhibition of virus replication, anti-inflammatory action, reduction of hypoxia, and reduction of the toxic effects of drug therapy may be very effective. The hypothesis of the expediency of treating systemic inflammation aimed at "quenching" the cytokine "storm", caused largely by the production of reactive oxygen species, seems essential. In this connection, it is pathophysiologically justified to use for prophylactic and therapeutic purposes antioxidant drugs, which have proven themselves on the example of other viral respiratory infections. Thus, the high activity of preparations of vitamin C, N-acetylcysteine, melatonin, quercetin, glutathione, astaxanthin, polyphenols, polyunsaturated fatty acids, etc. was noted. In addition, these drugs effectively protect the vascular wall, which has been proven for a number of cardiovascular diseases and that can be effective in developing with COVID-19 vasculitis. There is a more pronounced combined effect of these drugs, which is already used in treatment protocols for patients with SARS-CoV-2. Special attention should also be paid to the use of antioxidant drugs as a means to reduce the toxic manifestations of antiviral therapy. Thus, the use of drugs with antioxidant activity can be justified and will certainly improve the effectiveness of the fight against the pandemic of new coronavirus infection.Keywords
This publication has 31 references indexed in Scilit:
- The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal ModelsJournal of Comparative Pathology, 2014
- Respiratory Viral Infections and Subversion of Cellular Antioxidant DefensesJournal of Pharmacogenomics & Pharmacoproteomics, 2014
- Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study GroupJournal of Virology, 2013
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung InjuryCell, 2008
- Upregulation of Mitochondrial Gene Expression in PBMC from Convalescent SARS PatientsJournal of Clinical Immunology, 2006
- Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosisFEMS Immunology & Medical Microbiology, 2006
- The Molecular Inflammatory Process in AgingAntioxidants and Redox Signaling, 2006
- Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytesFree Radical Biology & Medicine, 2005
- The interaction of the SARS coronavirus non-structural protein 10 with the cellular oxido-reductase system causes an extensive cytopathic effectJournal of Clinical Virology, 2005
- Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cellsVirology, 2004